UK-based GlySure has completed patient enrollment for the multicenter CE Mark trial of its in-hospital continuous blood glucose monitoring (CBGM) system. The trial, led by principal investigator Dr Krishna Prasad, comprised 30 post ...
Tags: CE Mark Trial, Glysure
Direct Flow Medical, a developer of novel transcatheter heart valve technologies, has met its primary endpoint in the Discover CE Mark Trial by achieving 99% freedom from all-cause mortality at 30 days. The trial had enrolled 100 patients ...
Tags: Aortic Valve, Medicine
CircuLite has received an approval from the Federal Agency for Medicines and Health Products to begin the CE Mark trial of the Synergy IC Circulatory Support System (SICSS), which is designed for interventional cardiologist cannula ...
Tags: Circulite, CE Mark Trial